Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	214.46	-1141.65	363.05
Graham Fair Price	-11.19	40.40	45.49
PEG	-105.67	-0.92	-0.45
Price/Book	15.90	2.20	1.90
Price/Cash Flow	82.33	18.25	10.01
Prices/Earnings	44.94	26.25	18.11
Price/Sales	13.54	5.70	5.02
Price/FCF	82.33	18.25	10.01
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-91.13	0.07	0.80
ROA	-21.18	< 0.005	< 0.005
ROE	0.03	0.02	-20.04
ROIC	0.09	< 0.005	-90.70
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.10	-58.09
Dividends QOQ	< 0.005	0.01	93.76
EBIT QOQ	4.06	-0.91	-77.58
EPS QOQ	-0.41	-0.29	29.52
FCF QOQ	0.21	-0.37	71.98
Revenue QOQ	0.38	0.01	-96.51
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	1861.53	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.59	0.58	-1.38
Quick Ratio	2.23	24.15	985.43
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	59.29	58.88	-0.69
Cash	55.09	63.90	15.99
Capex	-0.27	-0.28	-4.45
Free Cash Flow	11.23	7.09	-36.87
Revenue	22.37	22.68	1.38
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.56	2.89	411.86
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	92.75	-190.32	105.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating